» Articles » PMID: 40057772

Diabetes Status, Duration, and Risk of Dementia Among Ischemic Stroke Patients

Overview
Date 2025 Mar 8
PMID 40057772
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The influence of duration of type 2 diabetes mellitus (T2DM) on the likelihood of developing new-onset dementia in post-stroke population is not well understood. Therefore, we aimed to clarify the relationship between the duration of T2DM and the risk of developing dementia in the post-stroke population.

Methods: Leveraging the Korean National Health Insurance Database, this study included 118,790 individuals with a history of stroke but no previous dementia diagnosis. We classified diabetes status into five categories: normoglycemia, impaired fasting glucose (IFG), newly diagnosed T2DM, and established T2DM with durations of less than 5 years and 5 years or more. The primary endpoint was the incidence of all-cause dementia.

Results: Among 118,790 participants (average age 64.26 ± 9.95 years, 48% male), 16.7% developed dementia during an average follow-up of 7.3 ± 2.3 years. Participants with a history of T2DM for less than five years at cohort entry had a 26.7% higher risk of developing all-cause dementia compared to those with normoglycemia. Those with T2DM for five years or longer had a 46.7% increased risk, with an adjusted hazard ratio (aHR) of 1.466 (95% confidence interval [CI], 1.408-1.527). Specifically, the risk of developing Alzheimer's disease (AD) and vascular dementia (VaD) rose by 43.4% and 51.4%, respectively, for individuals with T2DM lasting more than five years (aHR 1.434, 95% CI 1.366-1.505; aHR 1.514, 95% CI 1.365-1.679, respectively).

Conclusions: Our findings demonstrated a significant association between an extended duration of T2DM and an increased risk of developing all-cause dementia, including AD and VaD in post-stroke population. These results emphasize proactive dementia prevention approaches in stroke survivors, particularly those with longstanding T2DM.

References
1.
Hachinski V, Einhaupl K, Ganten D, Alladi S, Brayne C, Stephan B . Preventing dementia by preventing stroke: The Berlin Manifesto. Alzheimers Dement. 2019; 15(7):961-984. PMC: 7001744. DOI: 10.1016/j.jalz.2019.06.001. View

2.
van der Flier W, van Straaten E, Barkhof F, Verdelho A, Madureira S, Pantoni L . Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study. Stroke. 2005; 36(10):2116-20. DOI: 10.1161/01.STR.0000179092.59909.42. View

3.
Wang Q, Zhao K, Cai Y, Tu X, Liu Y, He J . Prediabetes is associated with post-stroke cognitive impairment in ischaemic stroke patients. Brain Res. 2018; 1687:137-143. DOI: 10.1016/j.brainres.2017.12.034. View

4.
Campbell J, Stephenson M, de Courten B, Chapman I, Bellman S, Aromataris E . Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis. J Alzheimers Dis. 2018; 65(4):1225-1236. PMC: 6218120. DOI: 10.3233/JAD-180263. View

5.
Choi E . Cardiovascular Research Using the Korean National Health Information Database. Korean Circ J. 2020; 50(9):754-772. PMC: 7441000. DOI: 10.4070/kcj.2020.0171. View